Unknown Glucose Metabolism Disorders In Patients With Coronary Artery Disease
NCT ID: NCT01310556
Last Updated: 2011-06-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
230 participants
OBSERVATIONAL
2009-06-30
2010-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Screen of DM by OGTT in Subjects Receiving CAG or MDCT for CAD
NCT01198730
Evaluation of the Prevalence of anomalIes of Glucose Metabolism in Patients Undergoing a Coronary Artery Bypass Graft (CABG)
NCT02855879
Relations Between Atherogenic Index of Plasma-Glucose Metabolism
NCT02977598
Turkish Nationwide SurvEy of Glycemic and Other Metabolic Parameters of Patients With Diabetes Mellitus
NCT03455101
Effect of Intensive Monitoring of Patients With Poorly Controlled Type 2 Diabetes With Different Glycemic Background
NCT06385899
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Settings: 230 patients with coronary artery disease and without any known GMDs were included the study. Coronary angiography was used to diagnose CAD. Patients were administered the 75 g Oral Glucose Tolerance Test (OGTT).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
coronary artery disease
patients with coronary artery disease
ogtt for patients with coronary artery disease
75 g OGTT
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ogtt for patients with coronary artery disease
75 g OGTT
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
30 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gulhane School of Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dep. of Endocrinology and Metabolism
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Aydogan Aydogdu, MD
Role: STUDY_DIRECTOR
Gulhane School of Medicine Ankara/Turkey
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gulhane School of Medicine
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
12.05.2009-131-1068
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.